Background Visceral leishmaniasis (VL) is diagnosed by microscopic confirmation of the parasite in bone marrow, spleen or lymph node aspirates. These procedures are unsuitable for rapid diagnosis of VL in field settings. The development of rK39-based rapid diagnostic tests (RDT) revolutionized diagnosis of VL by offering high sensitivity and specificity in detecting disease in the Indian subcontinent; however, these tests have been less reliable in the African subcontinent (sensitivity range of 75–85%, specificity of 70–92%). We have addressed limitations of the rK39 with a new synthetic polyprotein, rK28, followed by development and evaluation of two new rK28-based RDT prototype platforms. Methodology/Principal Findings Evaluation of 62 VL-confirmed sera from Sudan provided sensitivities of 96.8% and 93.6% (95% CI = K28: 88.83–99.61%; K39: 84.30–98.21%) and specificities of 96.2% and 92.4% (95% CI = K28: 90.53–98.95%; K39: 85.54–96.65%) for rK28 and rK39, respectively. Of greater interest was the observation that individual VL sera with low rK39 reactivity often had much higher rK28 reactivity. This characteristic of the fusion protein was exploited in the development of rK28 rapid tests, which may prove to be crucial in detecting VL among patients with low rK39 antibody levels. Evaluation of two prototype lateral flow-based rK28 rapid tests on 53 VL patients in Sudan and 73 VL patients in Bangladesh provided promisingly high sensitivities (95.9% [95% CI = 88.46–99.1 in Sudan and 98.1% [95% CI = 89.93–99.95%] in Bangladesh) compared to the rK39 RDT (sensitivities of 86.3% [95% CI = 76.25–93.23%] in Sudan and 88.7% [95% CI = 76.97–95.73%] in Bangladesh). Conclusions/Significance Our study compares the diagnostic accuracy of rK39 and rK28 in detecting active VL cases and our findings indicate that rK28 polyprotein has great potential as a serodiagnostic tool. A new rK28-based RDT will prove to be a valuable asset in simplifying VL disease confirmation at the point-of-care.
References
[1]
Rittig MG, Bogdan C (2000) Leishmania-host-cell interaction: complexities and alternative views. Parasitol Today 16: 292–297. doi: 10.1016/S0169-4758(00)01692-6
[2]
Harith AE, Kolk AH, Kager PA, Leeuwenburg J, Muigai R, et al. (1986) A simple and economical direct agglutination test for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis. Trans R Soc Trop Med Hyg 80: 583–536. doi: 10.1016/0035-9203(86)90149-5
[3]
Chappuis F, Mueller Y, Nguimfack A, Rwakimari JB, Couffignal S, et al. (2005) Diagnostic accuracy of two rK39 antigen-based dipsticks and the formol gel test for rapid diagnosis of visceral leishmaniasis in northeastern Uganda. J Clin Microbiol 43: 5973–5977. doi: 10.1128/JCM.43.12.5973-5977.2005
[4]
Pedras MJ, de Gouvea Viana L, de Oliveira EJ, Rabello A (2008) Comparative evaluation of direct agglutination test, rK39 and soluble antigen ELISA and IFAT for the diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg 102: 172–178. doi: 10.1016/j.trstmh.2007.11.004
[5]
Burns JM Jr, Shreffler WG, Benson DR, Ghalib HW, Badaro R, et al. (1993) Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc Natl Acad Sci U S A 90: 775–779. doi: 10.1073/pnas.90.2.775
[6]
Badaro R, Benson D, Eulalio MC, Freire M, Cunha S, et al. (1996) rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J Infect Dis 173: 758–761. doi: 10.1093/infdis/173.3.758
[7]
Zijlstra EE, Nur Y, Desjeux P, Khalil EA, El-Hassan AM, et al. (2001) Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan. Trop Med Int Health 6: 108–113. doi: 10.1046/j.1365-3156.2001.00680.x
[8]
Sundar S, Maurya R, Singh RK, Bharti K, Chakravarty J, et al. (2006) Rapid, noninvasive diagnosis of visceral leishmaniasis in India: comparison of two immunochromatographic strip tests for detection of anti-K39 antibody. J Clin Microbiol 44: 251–253. doi: 10.1128/JCM.44.1.251-253.2006
[9]
Sundar S, Reed SG, Singh VP, Kumar PC, Murray HW (1998) Rapid accurate field diagnosis of Indian visceral leishmaniasis. Lancet 351: 563–565. doi: 10.1016/S0140-6736(97)04350-X
[10]
Boelaert M, El-Safi S, Hailu A, Mukhtar M, Rijal S, et al. (2008) Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent. Trans R Soc Trop Med Hyg 102: 32–40. doi: 10.1016/j.trstmh.2007.09.003
[11]
Bhatia A, Daifalla NS, Jen S, Badaro R, Reed SG, et al. (1999) Cloning, characterization and serological evaluation of K9 and K26: two related hydrophilic antigens of Leishmania chagasi. Mol Biochem Parasitol 102: 249–261. doi: 10.1016/S0166-6851(99)00098-5
[12]
Rosati S, Ortoffi M, Profiti M, Mannelli A, Mignone W, et al. (2003) Prokaryotic expression and antigenic characterization of three recombinant Leishmania antigens for serological diagnosis of canine leishmaniasis. Clin Diagn Lab Immunol 10: 1153–1156. doi: 10.1128/cdli.10.6.1153-1156.2003
[13]
Boarino A, Scalone A, Gradoni L, Ferroglio E, Vitale F, et al. (2005) Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol 12: 647–653. doi: 10.1128/CDLI.12.5.647-653.2005
[14]
Scheel CM, Handali S, Bueno EC, Khan A, Hancock K, et al. (2006) Development of a normal human immunoglobulin G standard curve for enzyme-linked immunosorbent assay: use for comparison of antigen efficacy. J Immunoassay Immunochem 27: 173–181. doi: 10.1080/15321810600573028
[15]
Dapra F, Scalone A, Mignone W, Ferroglio E, Mannelli A, et al. (2008) Validation of a recombinant based antibody ELISA for diagnosis of human and canine leishmaniasis. J Immunoassay Immunochem 29: 244–256. doi: 10.1080/15321810802116006
[16]
Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39: 561–577.
[17]
Alce TM, Gokool S, McGhie D, Stager S, Smith DF (1999) Expression of hydrophilic surface proteins in infective stages of Leishmania donovani. Mol Biochem Parasitol 102: 191–196. doi: 10.1016/S0166-6851(99)00074-2
[18]
Gerald NJ, Coppens I, Dwyer DM (2007) Molecular dissection and expression of the LdK39 kinesin in the human pathogen, Leishmania donovani. Mol Microbiol 63: 962–979. doi: 10.1111/j.1365-2958.2006.05487.x
[19]
McKean PG, Trenholme KR, Rangarajan D, Keen JK, Smith DF (1997) Diversity in repeat-containing surface proteins of Leishmania major. Mol Biochem Parasitol 86: 225–235. doi: 10.1016/S0166-6851(97)00035-2
[20]
McFall RM, Treat TA (1999) Quantifying the information value of clinical assessments with signal detection theory. Annu Rev Psychol 50: 215–241. doi: 10.1146/annurev.psych.50.1.215
[21]
Langlotz CP (2003) Fundamental measures of diagnostic examination performance: usefulness for clinical decision making and research. Radiology 228: 3–9. doi: 10.1148/radiol.2281011106
[22]
Goto Y, Carter D, Guderian J, Inoue N, Kawazu SI, et al. (2010) Up-regulated expression of a B-cell antigen family tandem repeat proteins by Leishmania amastigotes. Infect Immun. doi: 10.1128/iai.01102-09
[23]
Goto Y, Carter D, Reed SG (2008) Immunological dominance of Trypanosoma cruzi tandem repeat proteins. Infect Immun 76: 3967–3974. doi: 10.1128/IAI.00604-08
[24]
Goto Y, Coler RN, Guderian J, Mohamath R, Reed SG (2006) Cloning, characterization, and serodiagnostic evaluation of Leishmania infantum tandem repeat proteins. Infect Immun 74: 3939–3945. doi: 10.1128/IAI.00101-06
[25]
Goto Y, Coler RN, Reed SG (2007) Bioinformatic identification of tandem repeat antigens of the Leishmania donovani complex. Infect Immun 75: 846–851. doi: 10.1128/IAI.01205-06
[26]
Burns JM Jr, Shreffler WG, Rosman DE, Sleath PR, March CJ, et al. (1992) Identification and synthesis of a major conserved antigenic epitope of Trypanosoma cruzi. Proc Natl Acad Sci U S A 89: 1239–1243. doi: 10.1073/pnas.89.4.1239
